Cost-effectiveness of Helicobacter pylori eradication therapy at a company occupational health clinic in Japan

Journal of UOEH

Volumn 24, Issue 2, 2002, Pages 161-176

  Yamasaki, Takuji ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cost effectiveness; Helicobacter pylori eradication therapy; Maintenance therapy with H2 blockers

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; COST EFFECTIVENESS ANALYSIS; ERADICATION THERAPY; EXPERIENCE; FEMALE; HELICOBACTER PYLORI; HUMAN; JAPAN; LIFE EXPECTANCY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; OCCUPATIONAL HEALTH; PRESCRIPTION; RECURRENT PEPTIC ULCER; REMISSION; RISK BENEFIT ANALYSIS; ULCER HEALING;

EID: 0036608812     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.24.161     Document Type: Article

References (49)

1. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years
2. Long-term therapy of peptic ulcer: Our experience with ranitidine after 4 years
3. Six years of continuous cimetidine treatment in peptic ulcer disease: Efficacy and safety
4. Efficacy and safety of long-term maintenance therapy of duodenal ulcers
5. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease
6. 2-receptor antagonists and duodenal ulcer recurrence: Analysis of efficacy and commentary on safety, costs, and patient selection
7. Helicobacterpylori in peptic ulcer disease
8. Effect of treatment Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer
9. Long-term consequences of Helicobacter pylori eradication
10. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacterpylori
11. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomized controlled trial
12. Maintenance therapy for duodenal ulcer: A randomized controlled comparison of seven forms of treatments
13. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer
14. Prospective, randomized investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers: Healing and long-term relapse rates
15. A study on the correlation of duodenal ulcer healing with Campylobacter-like organisms
16. Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow-up
17. Duodenal ulcer relapse after cimetidine withdrawal
18. Recurrent ulcer after successful treatment with cimetidine or antiacid
19. 2-antagonist treatment
20. Review of peptic ulcer maintenance trials
21. Does long-term maintenance-therapy with ranitidine after the natural course of duodenal ulcer disease?
22. Helicobacter pylori
23. Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: A double-blind controlled study
24. Is Helicobacter pylori the cause of dyspepsia?
25. Helicobacter pylori infection and the risk for duodenal and gastric ulceration
26. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients
27. The role of Campylobacter (Helicobacter) pylori in disorders of the gastrointestinal tract
28. Campylobacter pyloridis-associated chronic active antral gastritis
29. Screening dyspepsia by serology to Helicobacter pylori
30. Possible role of Helicobacter pylori serology in reducing endoscopy workload
31. Salivary antibodies to Helicobacter pylori screening dyspeptic patients before endoscopy
32. Helicobacter pylori infection in elderly dyspeptic patients
33. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy
34. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age
35. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy
36. Presence of Helicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characteristics
37. Factors influencing the eradication of Helicobacter pylori with triple therapy
38. Decision analysis and clinical judgment
39. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacterpylori
40. 2 antagonist use at a veterans affairs medical center
41. Costs of medical and surgical treatment of duodenal ulcer
42. High dose amoxicillin plus omeprazole in eradicating H. pylori
43. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada
44. A cost analysis of alternative treatments for duodenal ulcer
45. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer
46. Costs of duodenal ulcer therapy with antibiotics
47. The cost-effectiveness of Helicobacterpylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden
48. Cost-effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age
49. 2-receptor antagonists in general practice: Clinical and financial consequences of eradication using omeprazole plus amoxicillin or triple therapy